Author

Roweena Corpuz

Observed name: R. Corpuz

Institution: Genentech

Observed institutions: Western University, Genentech, London Health Sciences Centre

OpenAlex ID: A5053150307

A prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)

2017 · G.A. Davies, A. Lazo-Langner, et al. · Thrombosis Research · 98

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

A Prospective Cohort Study of Upper Extremity Deep Vein Thrombosis

2015 · Alejandro Lazo-Langner, Susan R Kahn, et al. · Blood · 5

Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19

2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4

Post-Thrombotic Syndrome and Functional Disability in Patients with Upper Extremity Deep Vein Thrombosis: A Prospective Cohort Study

2016 · Alejandro Lazo-Langner, Susan R Kahn, et al. · Blood · 3

A Pilot Study in Cancer Patients with Central Venous Catheter Associated Deep Vein Thrombosis in Upper Extremity Treated with Rivaroxaban (Catheter 2)

2016 · Gwynivere A Davies, Alejandro Lazo-Langner, et al. · Blood · 3

Structural Basis for Inhibition of IL-33 Induced ST2 Activation by Astegolimab

2025 · S.K. Ravala, P. Dutka, et al. · American Journal of Respiratory and Critical Care Medicine · 2

Works count: 8

Citation count: 190

H-index: 4

I10-index: 3